irofulven has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biersack, B; Knauer, S; Ocker, M; Schobert, R | 1 |
| Kulke, MH | 1 |
1 review(s) available for irofulven and Cancer of Pancreas
| Article | Year |
|---|---|
Advanced pancreatic cancer: is there a role for combination therapy?
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cysteine Endopeptidases; Deoxycytidine; Fluorouracil; Gemcitabine; Genes, ras; Glutamates; Guanine; Humans; Multienzyme Complexes; Pancreatic Neoplasms; Pemetrexed; Protease Inhibitors; Proteasome Endopeptidase Complex; Protein-Tyrosine Kinases; Sesquiterpenes | 2003 |
1 other study(ies) available for irofulven and Cancer of Pancreas
| Article | Year |
|---|---|
Conjugates of the fungal cytotoxin illudin M with improved tumour specificity.
Topics: Agaricales; Cell Line, Tumor; Chlorambucil; Colonic Neoplasms; Cytotoxins; Dicarboxylic Acids; Docosahexaenoic Acids; Esters; Fibroblasts; Humans; Pancreatic Neoplasms; Polycyclic Sesquiterpenes; Sesquiterpenes; Structure-Activity Relationship; Toxicity Tests | 2008 |